+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Ulcerative Colitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
Cell Therapy Global Market Report 2024 - Product Thumbnail Image

Cell Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Injectable Hematology Growth Factors Report - Product Thumbnail Image

Injectable Hematology Growth Factors Report

  • Report
  • January 2024
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Loading Indicator